Systematic evaluation of personal genome services for Japanese individuals.

Abstract excerpt

Disease risk prediction (DRP) is one of the most important challenges in personal genome research. Although many direct-to-consumer genetic test (DTC) companies have begun to offer personal genome services for DRP, there is still no consensus on what constitutes a gold-standard service. Here, we systematically evaluated the distributions of DRPs from three DTC companies, that is, 23andMe, Navigenics and deCODEme,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Asian People
• Share to Genetic Testing
• Share to Genome, Human